[go: up one dir, main page]

EA201791233A1 - Материал стволовых клеток и способ его получения - Google Patents

Материал стволовых клеток и способ его получения

Info

Publication number
EA201791233A1
EA201791233A1 EA201791233A EA201791233A EA201791233A1 EA 201791233 A1 EA201791233 A1 EA 201791233A1 EA 201791233 A EA201791233 A EA 201791233A EA 201791233 A EA201791233 A EA 201791233A EA 201791233 A1 EA201791233 A1 EA 201791233A1
Authority
EA
Eurasian Patent Office
Prior art keywords
msc
stem cell
conditioned
preparation
cell material
Prior art date
Application number
EA201791233A
Other languages
English (en)
Inventor
Анатолий Андреевич Соколов
Антонина Ивановна Колесникова
Андрей Игоревич Довгий
Original Assignee
Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" filed Critical Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"
Publication of EA201791233A1 publication Critical patent/EA201791233A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/185—Osteoprotegerin; Osteoclast differentiation factor (ODF, RANKL)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)

Abstract

Аспекты настоящего изобретения относятся к новой линии мезенхимальных стволовых клеток (hb-MSC), культуральной среде, кондиционированной линией hb-MSC, и различным композициям hb-MSC. Композиция hb-MSC может включать множество hb-MSC, среду, кондиционированную hb-MSC, или их комбинацию. Композиция hb-MSC может также включать приемлемый носитель. Также описаны способы применения клеток hb-MSC, кондиционированной среды и их композиций.
EA201791233A 2014-12-01 2015-11-30 Материал стволовых клеток и способ его получения EA201791233A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2014148251A RU2644650C2 (ru) 2014-12-01 2014-12-01 Материал стволовых клеток и способ его получения
PCT/RU2015/000831 WO2016089252A1 (en) 2014-12-01 2015-11-30 Stem cell material and method of manufacturing

Publications (1)

Publication Number Publication Date
EA201791233A1 true EA201791233A1 (ru) 2017-09-29

Family

ID=56092075

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791233A EA201791233A1 (ru) 2014-12-01 2015-11-30 Материал стволовых клеток и способ его получения

Country Status (9)

Country Link
US (2) US10744160B2 (ru)
EP (1) EP3226876B1 (ru)
JP (2) JP7097698B2 (ru)
KR (2) KR102257386B1 (ru)
CN (1) CN107429228B (ru)
EA (1) EA201791233A1 (ru)
IL (1) IL252529B (ru)
RU (1) RU2644650C2 (ru)
WO (1) WO2016089252A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
MY196026A (en) * 2017-02-16 2023-03-07 Oct Therapies And Res Private Limited Stem Cell Conditioned Media for Clinical and Cosmetic Applications
KR101999818B1 (ko) * 2017-07-26 2019-07-12 ㈜로제타엑소좀 소수성 상호작용을 이용한 세포밖 소포체의 분리방법
CN108753684A (zh) * 2018-06-19 2018-11-06 山东信得科技股份有限公司 一种去除pk15细胞中支原体的方法
AU2020315475A1 (en) 2019-07-18 2022-02-03 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
FR2755371B1 (fr) 1996-11-07 1998-12-18 Oreal Composition cosmetique sous la forme d'un gel transparent moussant
EP2179738A3 (en) 1997-01-24 2010-05-05 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating osteoporosis
US20030103951A1 (en) 1997-07-14 2003-06-05 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
AU7067200A (en) 1999-08-23 2001-03-19 Organogenesis Inc. Skin care compositions and treatments
WO2001080865A2 (en) 2000-04-25 2001-11-01 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells
EP2206772A3 (en) 2000-12-06 2010-08-04 Robert J. Hariri Method of collecting placental stem cells
AU2002345603B2 (en) 2001-06-07 2006-10-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof
US20060083722A1 (en) 2001-07-18 2006-04-20 Advanced Cell Technology, Inc Methods and compositions for cell therapy
US20030232430A1 (en) 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
MXPA04006771A (es) 2002-01-14 2005-04-25 Ford Henry Health System Materiales de celulas estromaticas de medula osea para uso en la formacion de vasos sanguineos y en la produccion de factores angiogenicos y troficos.
AR047712A1 (es) 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
US8940535B2 (en) 2003-11-04 2015-01-27 University Of Maryland, Baltimore Stem cell culture medium and method of using said medium and the cells
KR100560340B1 (ko) 2003-11-11 2006-03-14 한훈 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법
NZ548623A (en) 2004-01-02 2010-04-30 Advanced Cell Tech Inc Novel culture systems for ex vivo development of stem cells in telolecithal or eutelolecithal eggs
US20050239897A1 (en) 2004-03-22 2005-10-27 Pittenger Mark F Mesenchymal stem cells and uses therefor
EP2269461B1 (en) * 2004-07-30 2017-03-22 Mayo Foundation For Medical Education And Research Treating cardiovascular tissue
KR100835738B1 (ko) 2004-08-02 2008-06-09 주식회사 삼양사 졸-젤 전이가 가능한 생분해성 다중블록 고분자 조성물 및이를 함유하는 약학적 조성물
US7354888B2 (en) 2004-11-10 2008-04-08 Danisco A/S Antibacterial composition and methods thereof comprising a ternary builder mixture
US8287853B2 (en) 2005-02-11 2012-10-16 Agency For Science, Technology And Research Methods of culturing mesenchymal stem cells
RU2292212C1 (ru) * 2005-06-02 2007-01-27 ГУ Медицинский радиологический научный центр РАМН Кондиционная среда, обладающая лечебным эффектом
PT2548951E (pt) 2006-03-23 2016-06-14 Pluristem Ltd Métodos para expansão celular e usos de células e de meios condicionados produzidos através deles para terapia
EP2054506A1 (en) 2006-08-15 2009-05-06 Agency for Science, Technology and Research Mesenchymal stem cell conditioned medium
US8021882B2 (en) 2006-08-24 2011-09-20 Johnstone Brian H Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
ITRM20060498A1 (it) 2006-09-20 2008-03-21 Alessandra Gambacurta Metodo di espansione di cellule staminali adulte da sangue periferico e relativi usi in campo medico
CA2665475A1 (en) * 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
WO2008070868A1 (en) 2006-12-07 2008-06-12 American Symbolic, Llc Stem cell secretions and related methods
US20100130415A1 (en) 2006-12-19 2010-05-27 Michael Cohen Stem cell secreted product derived compositions for wound treatment
RU2341270C2 (ru) 2006-12-28 2008-12-20 Александр Сергеевич Ботин Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
FR2912917B1 (fr) 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
WO2008116111A2 (en) 2007-03-20 2008-09-25 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
CA2629652A1 (en) 2007-04-24 2008-10-24 Yaojiong Wu Compositions for preventing or treating skin defects and methods of use thereof
WO2009007979A2 (en) 2007-07-11 2009-01-15 Technion Research & Development Foundation Ltd. Encapsulated mesenchymal stem cells and uses thereof
CN102014934B (zh) 2008-02-22 2014-08-20 新加坡科技研究局 间充质干细胞颗粒
US20100040583A1 (en) 2008-03-27 2010-02-18 Vincent Falanga Compositions and methods using stem cells in cutaneous wound healing
BRPI0909866B1 (pt) * 2008-06-11 2021-08-24 Fresenius Medical Care Deutschland Gmbh Método de produção de um meio condicionado de células progenitoras de fígado, meio condicionado e composição farmacêutica
RU2372933C1 (ru) 2008-06-19 2009-11-20 Вячеслав Михайлович Девиченский Лекарственное средство и лекарственная композиция для его изготовления
US20110177015A1 (en) 2008-10-05 2011-07-21 Hymie Friedlander Skin and hair care using extract from conditioned medium cultured by mesenchymal stem cells and other regenerative cells
TW201103572A (en) 2009-05-04 2011-02-01 Neostem Inc Method and composition for restoration of age-related tissue loss in the face or selected areas of the body
SG10201403202XA (en) 2009-07-23 2014-08-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
GB0916370D0 (en) 2009-09-18 2009-10-28 Avecia Biolog Ltd Compositions
WO2011042547A1 (en) 2009-10-08 2011-04-14 Projech Science To Technology, S.L. Myometrial-derived mesenchymal stem cells and uses thereof
KR101135636B1 (ko) 2009-10-27 2012-04-17 서울대학교산학협력단 인간 만능줄기세포로부터 중배엽 줄기세포를 생산하는 방법 및 이에 의해 생성된 중배엽 줄기세포
US20120263692A1 (en) 2009-11-16 2012-10-18 Bertone Alicia L Engineered Xenogeneic Cells for Repair of Biological Tissue
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
EP2506867B1 (en) 2009-12-02 2014-10-08 Cardio3 Biosciences S.A. Pharmaceutical compositions for the stimulation of stem cells.
EP2333047A1 (en) 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
US20130058903A1 (en) * 2009-12-10 2013-03-07 Techung Lee Stem-Cell Material and Method of Use
US8911963B2 (en) 2010-04-05 2014-12-16 Medstar Health Research Institute, Inc. Conditioned medium obtained from stem cells and its use in therapy
RU2432943C1 (ru) 2010-10-19 2011-11-10 Закрытое акционерное общество Научно-производственное предприятие "Агрофарм" Препарат для лечения мастита у коров в период лактации
EP2665482B1 (en) 2011-01-18 2017-10-11 Noveome Biotherapeutics, Inc. Wound healing device and method
US20120276215A1 (en) 2011-04-26 2012-11-01 Riordan Neil H Therapeutic Conditioned Media
ITMI20120338A1 (it) 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
RU2512681C2 (ru) 2012-08-22 2014-04-10 Антонина Ивановна Колесникова Способ лечения длительно незаживающей раны и/или раневой полости
MX2015002711A (es) * 2012-09-04 2015-06-05 Anthrogenesis Corp Metodos de generacion de tejidos.
ITTO20120859A1 (it) * 2012-10-02 2014-04-03 Univ Degli Studi Torino Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
WO2015028900A1 (en) 2013-08-29 2015-03-05 Stempeutics Research Pvt. Ltd. Stromal cells derived conditioned medium, method of obtaining said conditioned medium compositions, formulations and applications thereof

Also Published As

Publication number Publication date
EP3226876A4 (en) 2017-10-11
US10744160B2 (en) 2020-08-18
IL252529A0 (en) 2017-07-31
KR20210084527A (ko) 2021-07-07
IL252529B (en) 2021-08-31
JP7116501B2 (ja) 2022-08-10
RU2014148251A (ru) 2016-06-27
KR20170089924A (ko) 2017-08-04
EP3226876B1 (en) 2023-11-01
RU2644650C2 (ru) 2018-02-13
RU2017123284A3 (ru) 2019-06-24
WO2016089252A1 (en) 2016-06-09
EP3226876A1 (en) 2017-10-11
JP7097698B2 (ja) 2022-07-08
US20200360443A1 (en) 2020-11-19
CN107429228B (zh) 2024-04-05
KR102257386B1 (ko) 2021-05-27
JP2017536849A (ja) 2017-12-14
US20170326178A1 (en) 2017-11-16
RU2017123284A (ru) 2019-01-09
CN107429228A (zh) 2017-12-01
JP2021072789A (ja) 2021-05-13

Similar Documents

Publication Publication Date Title
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
EA201992001A1 (ru) Композиции и способы повышения экспрессии генов
MX2023011785A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
EA202192126A3 (ru) Способы сбора культур клеток млекопитающих
MX2020000621A (es) Composiciones para usarse en inmunomodulacion.
BR112018005937A2 (pt) conjugados de oligonucleotídeo de afinidade e usos destes
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
AR101845A1 (es) Anticuerpos anti-her2 e inmunoconjugados
EA201391523A1 (ru) Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
WO2015187825A3 (en) Compositions and methods for modulating dysferlin expression
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MX2019010492A (es) Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado.
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
EA201990128A1 (ru) Культуры клеточных линий из растений, принадлежащих к роду harpagophytum
DK3436568T3 (da) Kulturmedium til pluripotente stamceller
BR112018009097A8 (pt) spodoptera frugiperda resistente a vip3a
WO2015171852A3 (en) Methods and compositions for non-cytotoxic stem cell transplantation
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.
EA201890177A1 (ru) Мультиспецифические связывающие белки
MY178060A (en) Methods of preparing a poloxamer for use in cell culture medium
MX2017011648A (es) Metodos de piolisina y composiciones.
WO2015117033A3 (en) Methods of increasing protein production in mammalian cells